BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2857165)

  • 1. gamma-Glutamylcysteine and thiosulfate are the major low-molecular-weight thiols in halobacteria.
    Newton GL; Javor B
    J Bacteriol; 1985 Jan; 161(1):438-41. PubMed ID: 2857165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB; Hayward ML; Griffith OW
    Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments.
    Galván I; Wakamatsu K; Alonso-Alvarez C; Solano F
    Bioorg Med Chem Lett; 2014 May; 24(9):2150-4. PubMed ID: 24703231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of estrous cycle and buthionine sulfoximine on glutathione release from the in vitro perfused rat ovary.
    Clague N; Sevcik M; Stuart G; Brännström M; Janson PO; Jarrell JF
    Reprod Toxicol; 1992; 6(6):533-9. PubMed ID: 1363201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione biosynthesis in the isolated perfused rat lung: utilization of extracellular glutathione.
    Berggren M; Dawson J; Moldéus P
    FEBS Lett; 1984 Oct; 176(1):189-92. PubMed ID: 6149151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.
    Griffith OW
    J Biol Chem; 1982 Nov; 257(22):13704-12. PubMed ID: 6128339
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of glutathione biosynthesis by prothionine sulfoximine (S-n-propyl homocysteine sulfoximine), a selective inhibitor of gamma-glutamylcysteine synthetase.
    Griffith OW; Anderson ME; Meister A
    J Biol Chem; 1979 Feb; 254(4):1205-10. PubMed ID: 33187
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
    Griffith OW; Meister A
    J Biol Chem; 1979 Aug; 254(16):7558-60. PubMed ID: 38242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of glutamine and gamma-glutamylcysteine synthetases by alpha-alkyl analogs of methionine sulfoximine that induce convulsions.
    Griffith OW; Meister A
    J Biol Chem; 1978 Apr; 253(7):2333-8. PubMed ID: 24637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione biosynthesis and its inhibition.
    Meister A
    Methods Enzymol; 1995; 252():26-30. PubMed ID: 7476360
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and characterization of gamma-glutamylcysteine synthetase from Ascaris suum.
    Hussein AS; Walter RD
    Mol Biochem Parasitol; 1995 Jun; 72(1-2):57-64. PubMed ID: 8538700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of glutathione biochemistry and transport--selective alteration of glutathione metabolism.
    Meister A
    Nutr Rev; 1984 Dec; 42(12):397-410. PubMed ID: 6151157
    [No Abstract]   [Full Text] [Related]  

  • 14. Depletion of glutathione by inhibition of biosynthesis.
    Griffith OW
    Methods Enzymol; 1981; 77():59-63. PubMed ID: 6120437
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) activity by high-performance liquid chromatography and electrochemical detection.
    Gegg ME; Clark JB; Heales SJ
    Anal Biochem; 2002 May; 304(1):26-32. PubMed ID: 11969185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung.
    Thanislass J; Raveendran M; Devaraj H
    Biochem Pharmacol; 1995 Jul; 50(2):229-34. PubMed ID: 7632167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buthionine sulfoximine treatment impairs rat diaphragm function.
    Morales CF; Anzueto A; Andrade F; Brassard J; Levine SM; Maxwell LC; Lawrence RA; Jenkinson SG
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):915-9. PubMed ID: 7908245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the active site thiol of gamma-glutamylcysteine synthetase: relationships to catalysis, inhibition, and regulation.
    Huang CS; Moore WR; Meister A
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2464-8. PubMed ID: 2895925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic glutathione metabolism in mice acutely treated with lead acetate.
    Nakagawa K
    Jpn J Pharmacol; 1989 Oct; 51(2):173-9. PubMed ID: 2574245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
    Le CT; Hollaar L; van der Valk EJ; van der Laarse A
    J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.